Fundraising Fox

Octeta Therapeutics

Kalamazoo, US · Founded 2015 · Delaware LLC

Biotech

Founders & leadership

AS
Angeline ShashloExecutive

Board

MJ
Michael JandernoaMember of Board of Managers
DV
David Van AndelMember of Board of Managers
WU
William U ParfetMember of Board of Managers
RZ
Robert ZerbeMember of Board of Managers

Reported raises · per SEC filings

Form D private placements

$16.4M disclosed across 1 round · 2016

▶$16.4MraisedMay 2016 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael JandernoaDirector
  • Angeline ShashloExecutive Officer
  • Robert ZerbeDirector
  • David Van AndelExecutive Officer, Director
  • William U ParfetExecutive Officer, Director
Offering amount
$20M
Amount sold
$16.4M
First sale
May 2016
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Startup raises $40M in funding | Crain's Grand Rapids Businesscrainsgrandrapids.com · Apr 2017Cirius Therapeutics Completes $40 Million Series A Financing to Fund Phase 2b Study of MSDC-0602K in NASH, Adds to Executive Teamprnewswire.com · Apr 2017Cirius Therapeutics Closes up to $40m Series A Financing - FinSMEsfinsmes.com · Apr 2017

Frequently asked questions

How much funding has Octeta Therapeutics raised?
Octeta Therapeutics has disclosed $16.4M raised across 1 round.
Where is Octeta Therapeutics headquartered?
Octeta Therapeutics is headquartered in Kalamazoo, US.